Dr. Manuel Guillermo Iregui, MD

Dr. Iregui practices at Incyte Pathology - Sacred Heart Medical Center Branch in Spokane, Washington.

Dr. Iregui's NPI, 1598758484, was assigned on August 25, 2005. Dr. Iregui graduated from Colegio Mayor de Nuestra Señora del Rosario in 1991. Dr. Iregui's Indiana license number on file is 01082171A.

Dr. Iregui's primary practice is Incyte Pathology - Sacred Heart Medical Center Branch, at 101 W 8th Ave, Spokane, WA 99204. The practice phone is (509) 474-7370.

Dr. Iregui's primary practice is Incyte Pathology - Sacred Heart Medical Center Branch in Spokane, Washington. Dr. Iregui is also affiliated with Prov Sacred Hrt Med Ctr & Childs Hosp. The medical group on file is Providence Medical Group. Dmand AI also links Dr. Iregui to 4 more hospitals, 7 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iregui practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Iregui's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Iregui is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Iregui's licenses on file in 5 states: Indiana, Ohio, Iowa, Pennsylvania and Washington.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pulmonary fibrosis, pulmonary heart disease, sleep apnea and tobacco use among the conditions Dr. Iregui treats.

CMS data shows 729 Medicare services from Dr. Iregui across 8 procedure codes in 2024, for 291 Medicare patients. Medicare paid $58,784 for them.

CMS counts 291 Medicare patients who saw Dr. Iregui in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iregui's median patient age at 71, with 57% women.

In 2024, Dr. Iregui wrote 387 Medicare Part D claims for 94 patients. 34% of them were for generic drugs. CMS names the drug for 276 of them, across 5 drugs with 11 or more claims each, at $180,208 in total drug cost. In 2023, CMS named 545 claims across 9 drugs.

Dr. Iregui accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Iregui as offering telehealth.

Dmand AI links 6 papers to Dr. Iregui.

CMS Open Payments shows 7 general payments to Dr. Iregui from 3 drug and device companies from 2019 to 2025. Speaker and faculty fees make up the largest share, 89% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $2,355.

Dmand AI lists 1 award for Dr. Iregui, most recently CMS Stage 1 EHR in 2013.

Dr. Iregui graduated from Colegio Mayor de Nuestra Señora del Rosario in 1991. Dr. Iregui is a member of AASM, ACCP and SCCM.

Dr. Iregui is in network with 16 carriers, including Aetna, Highmark and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.